![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 12587 | Ordered by Person (ascending)
1 2 3 ... 92 93 94 ... 124 125 126 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Raquet, Line Stigen (Creoptix 202001– CEO before Mettler-Toledo + Qiagen) | Chief Executive Officer (CEO) | Spectris (Group) | Switzerland |
| Rasche, Michael (AstraZeneca 201707– promoted CCO at Definiens joined 201602 as SVP Global Sales before Ayoxxa + Dako) | Chief Commercial Officer (CCO) | AstraZeneca (Group) | Germany |
| Rasche, Thom (Earlybird 200809 Partner) | Partner (venture partner) | Earlybird (Group) | Germany |
| Raschke, Markus B. (Univ of Colorado 201407 Professor Dept of Physics + Chemistry + JILA) | Professor | University of Colorado | United States (USA) |
| Rasmus, Conrad (Protembis GmbH 2013– Managing Director + Co-Founder) | Managing Director | Protembis GmbH | Germany |
| Rasmussen, Lars (Lundbeck 201709 Board Chairman) | Board member, non-executive | Lundbeck (Group) | Denmark |
| Rasmussen, Randy (Idaho Technology 200701 COO) | Chief Operating Officer (COO) | Mérieux (Group) | United States (USA) |
| Rasser, Jacobus (Koos) (Argen-X 201203– IP Counsel before Howrey LLP + P&G) | IP Manager | Argenx (Argen-X) (Group) | Netherlands |
| Rastetter, William H. | n. a. | Biogen (Group) | United States (USA) |
| Rataj, Sue H. (Agilent 201509– Non-exec Board Member + Bayer 201204– Supervisory Board Member before BP retired 4/11) | Board member, non-executive | Agilent (Group) | United States (USA) |
| Rataul, Billoo (Paramit 202106 CEO + President) | Chief Executive Officer (CEO) | Tecan (Group) | United States (USA) |
| Ratcliff, Amber (Hamilton 200902 Distribution Relations Manager) | Sales Manager / Marketing Manager | Hamilton (Group) | United States (USA) |
| Ratcliffe, Andrew (Cellzome 200809– Director Chemistry before UCB Celltech) | n. a. | GSK (Group) | United States (USA) |
| Ratcliffe, Ian (Sands Capital 202402 Executive Managing Partner) | Managing Partner (investment firm) | Sands Capital Management LLC | United States (USA) |
| Ratcliffe, Ian (Stemgent 201303 CEO) | Chief Executive Officer (CEO) | ReproCell (Group) | United States (USA) |
| Rath, Anna (Vestaron 202103 CEO) | Chief Executive Officer (CEO) | Vestaron Corporation | United States (USA) |
| Rathmann, George B. | n. a. | Nuvelo (Group) | United States (USA) |
| Rathmann, Torsten (Werner Rathmann Maschinenbau GmbH 201106 Managing Director) | Managing Director | Werner Rathmann Maschinenbau GmbH | Germany |
| Raths, Jürgen (Paion 201509–201703 COO before Executive Insight + Correvio Intl + Arpida + Lilly LEFT 3/17) | Chief Operating Officer (COO) | Humanwell Healthcare (Group) | Germany |
| Ratliff, John (LabCorp 201707 CEO of Covance) | Chief Executive Officer (CEO) | LabCorp (Group) | United States (USA) |
| Ratti, Emiliangelo (Takeda 201708 Head Global CNS Therapeutic Area Unit) | President/Director/Head Business Group/Unit/Division | Takeda (Group) | Japan |
| Rattray, Karen (Thermo Fisher 201004) | n. a. | Thermo Fisher (Group) | United States (USA) |
| Rau, Joleen (DNA Script 202204 Corporate Communications) | Public Relations Manager / Investor Relations Manager | Rau Communications LLC | United States (USA) |
| Rauch, Yossi (Bonus BioGroup 2022008 Executive Chairman) | Board member, executive | Bonus BioGroup Ltd. (TASE: BONS.TA) | Israel |
| Rauen, Hans-Werner (Bayer 201501 Global Regulatory Affairs Manager Insecticides at Bayer CropScience) | Regulatory Affairs Manager | Bayer (Group) | Germany |
| Raupach, Georg (Bayer 201501 Global Product Manager Insecticides at Bayer CropScience) | Product Manager (personnel) | Bayer (Group) | Germany |
| Rausch, Oliver (Storm Therapeutics 201702 VP R&D before Cellzome + UCB Celltech + GSK) | Research & Development Manager | Storm Therapeutics Ltd. | United Kingdom (GB) |
| Raval, Adi (Illumina 202205 Media Relations) | Public Relations Manager / Investor Relations Manager | Illumina (Group) | United States (USA) |
| Raval, Avi (Synthego 202202– CFO before Perella Weinberg Partners + formerly JP Morgan) | Chief Financial Officer (CFO) | Synthego Corporation | United States (USA) |
| Ravenelle, François (Inversago Pharma 202308 CEO) | Chief Executive Officer (CEO) | Novo Group (Group) | Canada |
| Ravenhill, Neil (Interpublic Group 201401– Director Scienctific Communications Weber Shandwick London before Parexel) | Public Relations Manager / Investor Relations Manager | Interpublic Group (IPG) (Group) | United States (USA) |
| Ravens, Jens (Epigenomics 202304 CFO) | Chief Financial Officer (CFO) | Epigenomics (Group) | Germany |
| Ravenscroft, Tim (Lentigen 200801 CEO) | Chief Executive Officer (CEO) | Opus Bio Inc. | United States (USA) |
| Ravetch, Jeffrey (Rockefeller Univ 200910 Prof + Virdante Pharmaceuticals 200910 Founder) | Professor | Rockefeller University | United States (USA) |
| Ravindran, Sanuj (BridgeBio 201811 CEO of PellePharm Inc) | Chief Executive Officer (CEO) | BridgeBio (Group) | United States (USA) |
| Ravnsborg, Christian (Evosep 202310– VP Marketing before CEO + Bruker Daltonics) | Sales Manager / Marketing Manager | Evosep ApS | Denmark |
| Rawadi, Georges (LNC Therapeutics 201804– CEO before Celyad/Cardio3 BioSciences + Cellectis + Galapagos + ProStrakan) | Chief Executive Officer (CEO) | LNC Therapeutics (FR) | France |
| Rawcliffe, Adrian (Ad) (Adaptimmune 201909– CEO joined 201503 as CFO before GSK) | Chief Executive Officer (CEO) | Adaptimmune (Group) | United Kingdom (GB) |
| Ray, Debanjan (Synthekine 202301 CEO) | Chief Executive Officer (CEO) | Synthekine Inc. | United States (USA) |
| Ray, Millie (Column Group 202302 Partner) | Partner (venture partner) | Column Group LLC, The (TCG) | United States (USA) |
| Raya, Michael (Hikma 201507 Managing Director of West-Ward) | Managing Director | Hikma (Group) | United States (USA) |
| Raymond, Brad (Stifel 202212 Global Head of Investment Banking) | President/Director/Head Business Group/Unit/Division | Stifel (Group) | United States (USA) |
| Raymont, Michael (AVAC Ltd 201502 CEO) | Chief Executive Officer (CEO) | AVAC Ltd. | Canada |
| Raythatha, Jigar (Constellation 202106 CEO) | Chief Executive Officer (CEO) | MorphoSys (Group) | United States (USA) |
| Raz, Tamar (Hadassah 201510 CEO of Hadasit) | Chief Executive Officer (CEO) | Hadassah (HMO) (Group) | Israel |
| Rea, Janet R. (Poniard 200807– VP Regulatory Affairs before AVI BioPharma) | Regulatory Affairs Manager | Poniard Pharmaceuticals Inc. (Nasdaq: PARD) | United States (USA) |
| Rea, Kerry (Znomics 200711– CFO) | Chief Financial Officer (CFO) | Znomics Inc. | United States (USA) |
| Read, Ian C. (Pfizer 201012– CEO joined Pfizr 1978) | Chief Executive Officer (CEO) | Pfizer (Group) | United States (USA) |
| Réal, Cécile (Adebag 201112 President) | President/Director/Head Business Group/Unit/Division | Medicalps Association | France |
| Reason, Andrew (BioPharmaSpec 201802 CEO) | Chief Executive Officer (CEO) | BioPharmaSpec (Group) | United Kingdom (GB) |
| Reckmann, Bernd (Merck KGaA 1986–201604 Executive Board Member since 2007 RETIRED 4/16)) | Board member, executive | Merck (DE) (Group) | Germany |
| Record, Marina (Baillie Gifford 201907 Investment Manager) | Investment Manager | Baillie Gifford | United Kingdom (GB) |
| Recordati, Andrea (Recordati 201309– COO) | Chief Operating Officer (COO) | Recordati (Group) | Italy |
| Recordati, Giovanni (Recordati 200810 CEO) | Chief Executive Officer (CEO) | Recordati (Group) | Italy |
| Reda, Kareem (ElevateBio 202003– CBO before Evelo Biosciences + Celgene + Vertex Pharmaceuticals) | Chief Business Officer (CBO) | ElevateBio (Group) | United States (USA) |
| Reddy, Bharat (Catamaran Bio 202011 Senior Director of Business Development) | Business Development Manager / Strategy Manager | Catamaran Bio Inc. | United States (USA) |
| Reddy, Sai (deepCDR Biologics 202112 Founder + Associate Prof at ETH Zurich Dept of Biosystems Science + Engineering) | Company Founder | Alloy Therapeutics (Group) | Switzerland |
| Reddy, Venkat (Macrophage Pharma 202106– CEO joined 1/20 as CSO before Glenmark Pharma + Pfizer + Sanofi + Novartis) | Chief Executive Officer (CEO) | Macrophage Pharma Ltd. (MPL) | United Kingdom (GB) |
| Redmond, Cavan (Wyeth 200702 Ex VP BioPharma) | n. a. | Pfizer (Group) | United States (USA) |
| Redmond, Leo (Presidio 200801– CFO before Genentech) | Chief Financial Officer (CFO) | Presidio Pharmaceuticals Inc. | United States (USA) |
| Redpath, Stella (Millipore 200811 Group Product Manager) | Product Manager (personnel) | Merck (DE) (Group) | United States (USA) |
| Reed, Carol (Clinical Data 200510– before Genaissance) | n. a. | Clinical Data (Group) | United States (USA) |
| Reed, Jane (Linguamatics 201708 Head of Life Science Strategy) | Business Development Manager / Strategy Manager | Linguamatics Ltd. | United Kingdom (GB) |
| Reed, John C. (Sanofi 201807– Global Head RnD before Roche 2013–201804 Head of pRED LEFT) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | France |
| Reed, Thomas D. (Intrexon 201701 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Precigen (Group) | United States (USA) |
| Reeders, Stephen (MVM 202309) | Investment Manager | MVM (Medical Venture Managers) (Group) | United Kingdom (GB) |
| Rees, Jonathan D. (Jon) (MitoRx Therapeutics 202204 CEO formerly OBN 2005–201508 CEO STEPPED DOWN 8/15) | Chief Executive Officer (CEO) | MitoRx Therapeutics Ltd. | United Kingdom (GB) |
| Rees, Leigh (Agilent 201009 General Manager X-ray Diffraction) | Product Manager (personnel) | Agilent (Group) | United States (USA) |
| Rees, Lyn (Premaitha Health 201809 CEO) | Chief Executive Officer (CEO) | Yourgene Health (Group) | United Kingdom (GB) |
| Rees, Steve (AstraZeneca 201712 VP Discovery Biology) | n. a. | AstraZeneca (Group) | United Kingdom (GB) |
| Reese, David M. (Amgen 201810 EVP RnD) | Research & Development Manager | Amgen (Group) | United States (USA) |
| Reess, Jürgen (MoglingBio 202210 CEO + Co-Founder before Boehringer Ingelheim Pharma) | Chief Executive Officer (CEO) | MoglingBio Inc. | United States (USA) |
| Reeves, Kathryne (Illumina 202009– Chief Marketing Officer before Cardinal Health + Booz Allen Hamilton + AOL/TW) | Sales Manager / Marketing Manager | Illumina (Group) | United States (USA) |
| Regan, Brian (WCAS 201707 General Partner) | General Partner (venture partner) | Welsh, Carson, Anderson & Stowe (WCAS) | United States (USA) |
| Regev, Aviv (Roche 202008– Head of gRED before Broad Institute + Thermo Fisher SAB Member) | President/Director/Head Business Group/Unit/Division | Roche (Group) | United States (USA) |
| Régnavaque, Sandra (Andrew Lloyd Associates 201510) | Public Relations Manager / Investor Relations Manager | Andrew Lloyd & Associates (ALA) | United Kingdom (GB) |
| Regnier, Fred (Purdue Univ 201404 Prof Emeritus + Co-founder of Novilytic) | Professor | Purdue University | United States (USA) |
| Regonini, Barbara (Genenta Science 202109– Financial Director before OAM + KREnergy SpA + PriceWaterhousCoopers SpA) | Financial Manager (CFO, Financial Director, etc.) | Genenta Science (Group) | Italy |
| Reic, Iskra (AstraZeneca 202312 EVP Vaccines + Immune Therapies | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
| Reichenbach, Stephen E. (Univ Nebraska 200212 Professor + CEO + Founder of GC Image LLC) | Professor | University of Nebraska | United States (USA) |
| Reichman, Amir (BiondVax 202103– CEO before GSK Vaccines + Novartis Vaccines + NeuroDerm) | Chief Executive Officer (CEO) | Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) | Israel |
| Reicin, Alise (Tectonic Therapeutic 202010 CEO before Celgene + Merck (DE) 201505– Head Global ClinDev before MSD) | Chief Executive Officer (CEO) | Tectonic Therapeutic Inc. | United States (USA) |
| Reicin, Glenn (Sigilon Therapeutics 201906– CFO before Greyrock Biomedical Advisors + Skyline Ventures + Morgan Stanley) | Chief Financial Officer (CFO) | Eli Lilly (Group) | United States (USA) |
| Reid, Andy (Peak Scientific 201003 Territory Sales Manager CEE + CIS Countries) | Sales Manager / Marketing Manager | Peak Scientific (Group) | United Kingdom (GB) |
| Reid, Clifford (Complete Genomics 200810 CEO) | Chief Executive Officer (CEO) | BGI (CN) (Group) | United States (USA) |
| Reid, Jim (Sistemic 201201 CEO before Haptogen CEO) | Chief Executive Officer (CEO) | Sistemic Ltd. | United Kingdom (GB) |
| Reid, Laurence E. (Warp Drive Bio 201601 CEO) | Chief Executive Officer (CEO) | Revolution Medicines Inc. (RVMD) | United States (USA) |
| Reid, Mark (Genetix 200609 Non-Executive Director before CEO) | Chief Executive Officer (CEO) | Danaher (Group) | United Kingdom (GB) |
| Reid, Patrick (PeptiDream 202012 CEO) | Chief Executive Officer (CEO) | PeptiDream Inc. (JP) | Japan |
| Reid-Anderson, James W. P. (Jim) (Siemens 200711– CEO before Dade Behring President + CEO before CFO since 1996) | Chief Executive Officer (CEO) | Siemens (Group) | Germany |
| Reilly, John (Apic Bio 202301 CEO + Co-Founder) | Chief Executive Officer (CEO) | Apic Bio Inc. | United States (USA) |
| Reimann, Andreas (Agilent Technologes Sales & Services GmbH & Co. KG 200706) | n. a. | Agilent (Group) | Germany |
| Reimann, Lars (Eurofins 201802 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Eurofins (Group) | Luxembourg |
| Rein, Anne (Strategies & Image 201707 President) | Public Relations Manager / Investor Relations Manager | Strategies & Image SAS | France |
| Reindl, Max (Wavelight CEO + Founder) | Chief Executive Officer (CEO) | Novartis (Group) | Germany |
| Reine, Allan (Foghorn Therapeutics 201909– CFO before Pieris + Lombard Odier Asset Management + CIBC World Markets) | Chief Financial Officer (CFO) | Foghorn Therapeutics Inc. | United States (USA) |
| Reineccius, Gary (Univ Minnesota 201306 Professor + Director of Flavor Research + Education Center) | Professor | University of Minnesota | United States (USA) |
| Reineke, Sean (Evogen 200902 CEO) | Chief Executive Officer (CEO) | Evogen (Group) | United States (USA) |
| Reinhard, Christopher J. (Cardium Therapeutics 200510 before Collateral) | n. a. | Cardium Therapeutics Inc. | United States (USA) |
| Reinhard, Jost (Bayer 202306 Head of Cell + Gene Therapy at Pharma Division) | President/Director/Head Business Group/Unit/Division | Bayer (Group) | Germany |
1 2 3 ... 92 93 94 ... 124 125 126
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
